Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22921247 | 0.79 | AKR1B1 (0.36) | AKR1B1CYP1A2 | |
| SCHEMBL18896131 | 0.71 | AKR1B1 (0.40) | AKR1B1CYP1A2 | |
| SCHEMBL1966558 | 0.70 | CYP2C19 (0.37) | AKR1B1CYP1A2 | |
| SCHEMBL12092610 | 0.69 | AKR1B1 (0.48) | AKR1B1 | |
| SCHEMBL1106771 | 0.69 | AKR1B1 (0.48) | AKR1B1 | |
| SCHEMBL5009236 | 0.68 | CYP2C19 (0.31) | AKR1B1 | |
| SCHEMBL27683964 | 0.67 | CYP1A2 (0.48) | AKR1B1CYP1A2 | |
| SCHEMBL2557239 | 0.67 | CYP2C19 (0.34) | AKR1B1CYP1A2 | |
| Hydrochloric Acid SCHEMBL9981621 | 0.67 | GRM4 (0.44) | CYP1A2 | |
| SCHEMBL3019549 | 0.66 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210024447-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE | ESPERVITA THERAPEUTICS, INC. | 2021-01-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210024447-A1 | FUNCTIONALIZED LONG-CHAIN HYDROCARBON MONO- AND DI-CARBOXYLIC ACIDS AND THEIR USE FOR THE PREVENTION OR TREATMENT OF DISEASE | CPT1A, PPARG, PC | AKR1B1 154/4885CYP1A2 449/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.